Search
for
Sort by
Research 271–300 of 748
- Australasian Society for Dermatology Research Meeting, May 2006
- Highlights from the 68th Annual Meeting of the Society of Investigative Dermatology
- BJD Editor's Choice
- Anhidrotic effect of intradermal injections of botulinum toxin—A comparison of different products and concentrations
- Semidominant Inheritance in Epidermolytic Ichthyosis
- Novel mutations of the ABCA12, KRT1 and ST14 genes in three unrelated newborns showing congenital ichthyosis
- Building Models for Keratin Disorders
- Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions
- SATU KASUS DERMATOSIS PUSTULAR SUBKORNEAL YANG DITERAPI DENGAN KORTIKOSTEROID
- Beyond Expectations
- Disease severity scoring systems in dermatology
- 475 Paraoxonase 1 (PON1) L55M and Q192R polymorphisms, lipid profiles and psoriasis
- 476 Development of an intrinsic skin sensor for blood glucose level with CRISPR-mediated genome editing in epidermal stem cells
- BOOK REVIEWS
- TOXIC EPIDERMAL NECROLYSIS
- Next generation human skin constructs as advanced tools for drug development
- Histopathological and Ultrastructural Study of Ectodermal Dysplasia/Skin Fragility Syndrome
- Hair and Nail Relationship
- Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy
- Preparing regenerative therapies for clinical application: proposals for responsible translation
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Novel therapies for alopecia areata: The era of rational drug development
- Botanicals With Dermatologic Properties Derived From First Nations Healing: Part 1—Trees
- Skin in the Game: Stem Cells in Repair, Cancer, and Homeostasis
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- A novel homozygous variant in the dsp gene underlies the first case of non-syndromic form of alopecia
- Recurrent MBTPS2 variant c.970+5G>A in IFAP syndrome: a mutational hotspot
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Mesenchymal stem cell-derived exosomes for the treatment of skin and subcutaneous tissue diseases: current evidence from clinical trials
- Dermatology practice in a high-tech world